Goldman says sell Guzman Y Gomez and buy this ASX share

The broker thinks the Mexican food chain's shares are heading deep into the red.

| More on:
A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Guzman Y Gomez Ltd (ASX: GYG) shares have been strong performers since listing on the Australian share market earlier this year.

However, one leading broker is calling time on this rally and is urging investors to hit the sell button today.

Time to sell Guzman Y Gomez shares

According to a note out of Goldman Sachs, its analysts think the quick service restaurant (QSR) operator's shares could be overvalued at current levels.

This morning, the broker has initiated coverage on the company's shares with a sell rating and $33.20 price target.

Based on its current share price of $39.26, this implies potential downside of approximately 15.5% for Guzman Y Gomez shares over the next 12 months.

Although the broker acknowledges that Guzman Y Gomez is a high-quality QSR operator, it thinks the market is too ambitious on its growth expectations.

In addition, it highlights that there will be a significant number of shares coming out of escrow in the near future that could end up being sold.

Commenting on its sell rating, the broker said:

We consider Guzman to be a high quality QSR operator with multiple levers available to grow operations, as well as a high likelihood of exceeding FY25 prospectus forecasts. However, the basis of our Sell thesis is centered on 1) an overly ambitious long-term store expansion profile that has no recent successful precedent in the Australian market; and 2) a stretched valuation that has, inappropriately in our view, been pegged to the highest growth US-peers without taking into consideration the market differences and risks associated with an accelerated store expansion. Separately we note an overhang exists with c.13% of total shares expected to be released from escrow in March 2025 and the remaining c.40% in August 2025.

Instead of Guzman Y Gomez shares, Goldman is recommending another QSR operator.

Buy this stock instead

This morning, Goldman has also initiated coverage on KFC restaurant operator Collins Foods Ltd (ASX: CKF).

It has commenced coverage with a buy rating and $10.00 price target. This implies potential upside of almost 16% for investors from current levels.

It believes that the company's outlook is becoming more positive, which could make now the time to buy. It said:

Like many consumer companies, Collins has been unable to escape the rising cost and tough consumer environment which led to recent margin downgrades. However, we consider the outlook to be incrementally more positive with our Buy thesis centered on 1) a moderation of cost growth with wages, poultry, electricity and rent growth moderating, while oils and grains have returned to pre-covid levels; 2) improved discretionary spending in Collins' key states (Qld & WA) and potential for increased Digital sales penetration; and 3) Netherlands KFC presence reaching scale and improved KFC Europe margins long-term.

Motley Fool contributor James Mickleboro has positions in Collins Foods. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Collins Foods. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Broker Notes

Where to invest $10,000 in ASX 200 shares this month

Brokers think these shares could be top picks for your hard-earned money this month.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »